Prevalence of Depression Among Women Using Hormonal Contraceptives in Mogadishu, Somalia: A Cross-Sectional Study

References

• Lenjisa G. Addis Ababa University School of Public Health Department of Preventive Medicine Contraceptive Use and Depression Among Female Employees in Governmental Institution in Sebeta Town. Ethiopia: Oromia Regional State; 2016.
   Google Scholar
• illustrated Guide A. Doing what matters in times of stress: An illustrated guide.
   Google Scholar
• AAKGR ES. The association of contraceptive methods and depression. Iran J Nurs Midwifery Res. 2012.
   Google Scholar
• Alfaifi M, Najmi A, Swadi K, Almushtawi A, Jaddoh S. Prevalence of contraceptive use and its association with depression among women in the Jazan province of Saudi Arabia. J Family Med Prim Care. 2021;10(7):2503. doi:10.4103/jfmpc.jfmpc_1308_20
   PubMedGoogle Scholar
• Sopian MM, Abbas S, Teoh SH, Khan E, Hami R, Din SAT. Mental health and obesity: A narrative review. Pak J Med Health Sci. 2021;15(5):1468–1473. doi:10.53350/pjmhs211551468
   Web of Science ®Google Scholar
• Gregory AM, Van Der Ende J, Willis TA, Verhulst FC Parent-reported sleep problems during development and self-reported anxiety/depression, attention problems, and aggressive behavior later in life; 2008. Available from: http://archpedi.jamanetwork.com/. Accessed June 4, 2024.
   Google Scholar
• McKetta S, Keyes KM. Oral contraceptive use and depression among adolescents. Ann Epidemiol. 2019;29:46–51. doi:10.1016/j.annepidem.2018.10.002
   Web of Science ®Google Scholar
• Shakerinejad G, Hidarnia A, Motlagh ME, Karami K, Niknami S, Montazeri A. Factors predicting mood changes in oral contraceptive pill users. Reprod Health. 2013;10(1). doi:10.1186/1742-4755-10-45
   Google Scholar
• Jensen MCH, Jørgensen L, Gemzell-Danielsson K, Sundström Poromaa I, Schroll JB. Hormonal contraceptive use and depression. CochrDat Syst Rev. 2021;2021(1). doi:10.1002/14651858.CD013838
   Google Scholar
• Teal S, Edelman A. Contraception selection, effectiveness, and adverse effects: a review. JAMA. 2021;326(24):2507–2518. doi:10.1001/jama.2021.21392
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W. Hemostatic effects of a novel estradiol-based oral contraceptive an open-label, randomized, crossover study of estradiol valerate/dienogest versus Ethinylestradiol/Levonorgestrel. Drugs. 2011;11.
   Google Scholar
• Hugon-Rodin J, Gompel A, Plu-Bureau G. Mechanisms in endocrinology: Epidemiology of hormonal contraceptives-related venous thromboembolism. Eur J Endocrinol. 2014;171(6):R221–R230. doi:10.1530/EJE-14-0527
   PubMed Web of Science ®Google Scholar
• Hormonal contraception, mood and sexual function CECILIA LUNDIN; 2020. Avaiable from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420736. Accessed June 4, 2024.
   Google Scholar
• Hajek A, König HH. Prevalence and correlates of individuals screening positive for depression and anxiety on the phq-4 in the German general population: findings from the nationally representative German socio-economic panel (GSOEP). Int J Environ Res Public Health. 2020;17(21):1–11. doi:10.3390/ijerph17217865
   Web of Science ®Google Scholar
• Faizi N, Kazmi S. Universal health coverage - There is more to it than meets the eye. J Family Med Prim Care. 2017;6(1):169. doi:10.4103/jfmpc.jfmpc_13_17
   Google Scholar
• Kessler RC, Berglund P, Olga Demler M, et al. Avaiable from: http://stats.bls.gov/cps/cpstn1.htm. The Epidemiology of Major Depressive Disorder Results From the National Comorbidity Survey Replication (NCS-R).
   Google Scholar
• Andersen MN, Bech P, Csillag C. Development and remission of depressive symptoms and treatment with hormonal contraceptives. Oxf Med Case Reports. 2014;2014(3):63–64. doi:10.1093/omcr/omu025
   Google Scholar
• Williams L, Jacka F, Pasco J, et al. The prevalence of mood and anxiety disorders in Australian women. Australas Psych. 2010;18(3):250–255. doi:10.3109/10398561003731155
   Google Scholar
• Segebladh B, Borgström A, Odlind V, Bixo M, Sundström-Poromaa I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 2009;79(1):50–55. doi:10.1016/j.contraception.2008.08.001
   PubMed Web of Science ®Google Scholar
• Mekonnen BD, Wubneh CA. Prevalence and associated factors of contraceptive discontinuation among reproductive-age women in Ethiopia: using 2016 Nationwide Survey Data. Reprod Health. 2020;17(1). doi:10.1186/s12978-020-01032-4
   Web of Science ®Google Scholar
• Kungu W, Agwanda A, Khasakhala A. Prevalence of and factors associated with contraceptive discontinuation in Kenya. Afr J Prim Health Care Fam Med. 2022;14(1). doi:10.4102/phcfm.v14i1.2992
   Web of Science ®Google Scholar
• Alhusain F, Alkaabba F, Alhassan N, et al. Patterns and knowledge of contraceptive methods use among women living in Jeddah, Saudi Arabia. Saudi J Health Sci. 2018;7(2):121. doi:10.4103/sjhs.sjhs_8_18
   Google Scholar
• Chebet JJ, McMahon SA, Greenspan JA, et al. “Every method seems to have its problems”- Perspectives on side effects of hormonal contraceptives in Morogoro Region, Tanzania. BMC Women's Health. 2015;15(1). doi:10.1186/s12905-015-0255-5
   Google Scholar
• Durowade KA, Omokanye LO, Elegbede OE, et al. Barriers to contraceptive uptake among women of reproductive age in a semi-Urban community of Ekiti State, Southwest Nigeria. Ethiop J Health Sci. 2017;27(2):121–128. doi:10.4314/ejhs.v27i2.4
   PubMed Web of Science ®Google Scholar
• Gele AA, Musse FK, Qureshi S, Bartels S. Unmet needs for contraception: a comparative study among Somali immigrant women in Oslo and their original population in Mogadishu, Somalia. PLoS One. 2019;14(8):e0220783. doi:10.1371/journal.pone.0220783
   PubMed Web of Science ®Google Scholar
• Abdulahi M, Kakaire O, Namusoke F. Determinants of modern contraceptive use among married Somali women living in Kampala; A cross sectional survey. Reprod Health. 2020;17(1). doi:10.1186/s12978-020-00922-x
   Web of Science ®Google Scholar
• Naing L, Naing L, Winn T, Rusli BN. Practical Issues in Calculating the Sample Size for Prevalence Studies Practical Issues in Calculating the Sample Size for Prevalence Studies; 2006. Avaiable from: https://www.researchgate.net/publication/45459002. Accessed June 4, 2024.
   Google Scholar
• The Federal Republic Of Somalia. Avaiable from: www.nbs.gov.so. Accessed June 4, 2024.
   Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9 Validity of a Brief Depression Severity Measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1093/omcr/omu025
   PubMed Web of Science ®Google Scholar
• Singata-Madliki M, Hellencourt F, Lawrie TA, Balakrishna Y, Hofmeyr GJ. Effects of three contraceptive methods on depression and sexual function: an ancillary study of the ECHO randomized trial. Int J Gynecol Obstet. 2021;154(2):256–262. doi:10.1002/ijgo.13594
   Web of Science ®Google Scholar
• Charoenpaitoon S, Jirapongsuwan Phd A, Sangon Phd S, Sativipawee Phd P, Kalampakorn Phd S. Factors associated with depression among Thai female workers in the electronics industry. J Med Assoc Thailand. 2012;Vol 95.
   Google Scholar
• Coleman R, Morison L, Paine K, Powell RA, Walraven G. Women’s reproductive health and depression: a community survey in the Gambia, West Africa. Soc Psycht Epid. 2006;41(9):720–727. doi:10.1007/s00127-006-0085-8
   PubMed Web of Science ®Google Scholar